In this study, we provide evidence that the mitochondrial protease LonP1 can compensate when the proteasome is inhibited and that increased levels of LonP1 confer partial resistance against proteasome inhibitors in multiple myeloma. Here, LONP1 is linked to plasma cell myeloma.